These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Risperidone treatment of borderline personality disorder assessed by a borderline personality disorder-specific outcome measure: a pilot study. Friedel RO; Jackson WT; Huston CS; May RS; Kirby NL; Stoves A J Clin Psychopharmacol; 2008 Jun; 28(3):345-7. PubMed ID: 18480695 [No Abstract] [Full Text] [Related]
12. Acute movement disorders associated with the use of second-generation antipsychotics in borderline personality disorder: a meta-analysis. Willems AE; Tenback DE; Ingenhoven TJ; van Harten PN J Clin Psychopharmacol; 2014 Aug; 34(4):520-2. PubMed ID: 24911435 [No Abstract] [Full Text] [Related]
19. Clozapine for the Management of Suicidal Behavior in Borderline Personality Disorder Complicated by a Cancer Diagnosis: A Case Report and Review of the Literature. OʼLeary J; Purcell A; Hynes C; Huet J; Romanos M; McWilliams S J Clin Psychopharmacol; 2018 Dec; 38(6):642-644. PubMed ID: 30334867 [No Abstract] [Full Text] [Related]
20. The positive effect of alprazolam in the treatment of three patients with borderline personality disorder. Faltus FJ Am J Psychiatry; 1984 Jun; 141(6):802-3. PubMed ID: 6145360 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]